Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Preclinical Compound Profiling, Xenogen Biosciences
April 2005
SHARING OPTIONS:

Xenogen Biosciences introduced a new comprehensive compound profiling program aimed at preclinical testing during drug development. They offer a customized battery of pharmacological tests. These tests use animals to (i) assess the therapeutic efficacy of (optimized) lead compounds and/or drug development candidates by analyzing their effects on key physiological functions in animals, and (ii) screen for potential side effects caused by the administration of such compounds, and/or (iii) discover disease indications for such compounds that were not previously known, thus expanding the market potential of those drug candidates.
 
Xenogen Biosciences
845.371.2747
www.xenogen.com

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.